DrugPatentWatch Database Preview
Details for Biologics License Application: 761037
» See Plans and Pricing
Summary for BLA: 761037
| Tradename: | KEVZARA |
| Applicant: | Sanofi Synthelabo |
| Ingredient: | sarilumab |
| Patents: | 10 |
| Approval Date: | Apr 13, 2018 |
| Suppliers: see list | 1 |
US Patents for BLA: 761037
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Synthelabo | KEVZARA | sarilumab | INJECTABLE;INJECTION | 761037 | 001 | 2018-04-13 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
| Sanofi Synthelabo | KEVZARA | sarilumab | INJECTABLE;INJECTION | 761037 | 001 | 2018-04-13 | Start Trial | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) | 2033-10-31 | RX | search | |
| Sanofi Synthelabo | KEVZARA | sarilumab | INJECTABLE;INJECTION | 761037 | 001 | 2018-04-13 | Start Trial | THERASYN SENSORS, INC. (Eggertsville, NY) | 2033-03-14 | RX | search | |
| Sanofi Synthelabo | KEVZARA | sarilumab | INJECTABLE;INJECTION | 761037 | 001 | 2018-04-13 | Start Trial | TEN PEAKS LLC (Corona Del Mar, CA) | 2038-05-08 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
